Related Experiment Video

Updated: May 17, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Emerging molecular targets in melanoma invasion and metastasis

Jose L Orgaz1, Victoria Sanz-Moreno

  • 1Randall Division of Cell and Molecular Biophysics, King's College London, London, UK.

Pigment Cell & Melanoma Research
|October 26, 2012
PubMed

Insights

Metastatic cutaneous melanoma is aggressive and treatment-resistant. This review explores tumor cell plasticity, a key factor in melanoma metastasis, and its clinical applications for patient stratification and treatment.

Area of Science:

  • Oncology
  • Dermatology
  • Cell Biology

Background:

  • Metastatic cutaneous melanoma causes most skin cancer deaths.
  • Melanoma's aggressiveness and therapy resistance necessitate understanding its spread.
  • Metastasis involves cytoskeletal changes and altered cell-matrix interactions.

Purpose of the Study:

  • To review the role of tumor cell plasticity in melanoma metastasis.
  • To explore recent research findings in melanoma cell interconvertibility.
  • To identify clinical opportunities for melanoma patient stratification and treatment.

Main Methods:

  • Literature review of recent research (last 5 years).
  • Focus on tumor cell plasticity as a driver of metastasis.
  • Analysis of findings related to melanoma cell migratory strategies.

Main Results:

  • Melanoma cell plasticity enables adaptation to different environments for invasion.
  • Tumor cell interconvertibility is a significant factor in melanoma metastasis.
  • Extensive research has yielded numerous findings on melanoma cell behavior.

Conclusions:

  • Understanding melanoma cell plasticity offers new clinical avenues.
  • Potential for improved patient stratification based on migratory behavior.
  • New therapeutic strategies may emerge from insights into tumor cell plasticity.

More Related Videos

Experimental Metastasis Assay08:28

Experimental Metastasis Assay

Published on: August 24, 2010

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...